Cargando…

Robotic-Assisted Transperitoneal Aortic Lymphadenectomy as Part of Staging Procedure for Gynaecological Malignancies: Single Institution Experience

Introduction. This study was designed to confirm the feasibility and safety of robotic-assisted transperitoneal aortic lymphadenectomy as part of staging procedure for gynecologic malignancies. Methods. Chart review of 51 patients who had undergone robotic staging with aortic lymphadenectomy for dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanagnolo, V., Rollo, D., Tomaselli, T., Rosenberg, P. G., Bocciolone, L., Landoni, F., Aletti, G., Peiretti, M., Sanguineti, F., Maggioni, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747409/
https://www.ncbi.nlm.nih.gov/pubmed/23983700
http://dx.doi.org/10.1155/2013/931318
_version_ 1782280928778780672
author Zanagnolo, V.
Rollo, D.
Tomaselli, T.
Rosenberg, P. G.
Bocciolone, L.
Landoni, F.
Aletti, G.
Peiretti, M.
Sanguineti, F.
Maggioni, A.
author_facet Zanagnolo, V.
Rollo, D.
Tomaselli, T.
Rosenberg, P. G.
Bocciolone, L.
Landoni, F.
Aletti, G.
Peiretti, M.
Sanguineti, F.
Maggioni, A.
author_sort Zanagnolo, V.
collection PubMed
description Introduction. This study was designed to confirm the feasibility and safety of robotic-assisted transperitoneal aortic lymphadenectomy as part of staging procedure for gynecologic malignancies. Methods. Chart review of 51 patients who had undergone robotic staging with aortic lymphadenectomy for different gynaecologic malignancies was performed. Results. The primary diagnosis was as follows: 6 cases of endometrial cancer, 31 epithelial ovarian cancer, 9 nonepithelial ovarian cancer, 4 tubal cancer, and 1 cervical cancer. Median BMI was 23 kg/m(2). Except for a single case of aortic lymphadenectomy only, both aortic and pelvic lymphadenectomies were performed at the time of the staging procedure. All the para-aortic lymphadenectomies were carried out to the level of the renal veinl but 6 cases were carried out to the level of the inferior mesenteric artery. Hysterectomy was performed in 24 patiens (47%). There was no conversion to LPT. The median console time was 285 (range 195–402) with a significant difference between patients who underwent hysterectomy and those who did not. The median estimated blood loss was 50 mL (range 20–200). The mean number of removed nodes was 29 ± 9.6. The mean number of pelvic nodes was 15 ± 7.6, whereas the mean number of para-aortic nodes was 14 ± 6.6. Conclusions. Robotic transperitoneal infrarenal aortic lymphadenectomy as part of staging procedure is feasible and can be safely performed. Additional trocars are needed when pelvic surgery is also performed.
format Online
Article
Text
id pubmed-3747409
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-37474092013-08-27 Robotic-Assisted Transperitoneal Aortic Lymphadenectomy as Part of Staging Procedure for Gynaecological Malignancies: Single Institution Experience Zanagnolo, V. Rollo, D. Tomaselli, T. Rosenberg, P. G. Bocciolone, L. Landoni, F. Aletti, G. Peiretti, M. Sanguineti, F. Maggioni, A. Obstet Gynecol Int Clinical Study Introduction. This study was designed to confirm the feasibility and safety of robotic-assisted transperitoneal aortic lymphadenectomy as part of staging procedure for gynecologic malignancies. Methods. Chart review of 51 patients who had undergone robotic staging with aortic lymphadenectomy for different gynaecologic malignancies was performed. Results. The primary diagnosis was as follows: 6 cases of endometrial cancer, 31 epithelial ovarian cancer, 9 nonepithelial ovarian cancer, 4 tubal cancer, and 1 cervical cancer. Median BMI was 23 kg/m(2). Except for a single case of aortic lymphadenectomy only, both aortic and pelvic lymphadenectomies were performed at the time of the staging procedure. All the para-aortic lymphadenectomies were carried out to the level of the renal veinl but 6 cases were carried out to the level of the inferior mesenteric artery. Hysterectomy was performed in 24 patiens (47%). There was no conversion to LPT. The median console time was 285 (range 195–402) with a significant difference between patients who underwent hysterectomy and those who did not. The median estimated blood loss was 50 mL (range 20–200). The mean number of removed nodes was 29 ± 9.6. The mean number of pelvic nodes was 15 ± 7.6, whereas the mean number of para-aortic nodes was 14 ± 6.6. Conclusions. Robotic transperitoneal infrarenal aortic lymphadenectomy as part of staging procedure is feasible and can be safely performed. Additional trocars are needed when pelvic surgery is also performed. Hindawi Publishing Corporation 2013 2013-08-01 /pmc/articles/PMC3747409/ /pubmed/23983700 http://dx.doi.org/10.1155/2013/931318 Text en Copyright © 2013 V. Zanagnolo et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Zanagnolo, V.
Rollo, D.
Tomaselli, T.
Rosenberg, P. G.
Bocciolone, L.
Landoni, F.
Aletti, G.
Peiretti, M.
Sanguineti, F.
Maggioni, A.
Robotic-Assisted Transperitoneal Aortic Lymphadenectomy as Part of Staging Procedure for Gynaecological Malignancies: Single Institution Experience
title Robotic-Assisted Transperitoneal Aortic Lymphadenectomy as Part of Staging Procedure for Gynaecological Malignancies: Single Institution Experience
title_full Robotic-Assisted Transperitoneal Aortic Lymphadenectomy as Part of Staging Procedure for Gynaecological Malignancies: Single Institution Experience
title_fullStr Robotic-Assisted Transperitoneal Aortic Lymphadenectomy as Part of Staging Procedure for Gynaecological Malignancies: Single Institution Experience
title_full_unstemmed Robotic-Assisted Transperitoneal Aortic Lymphadenectomy as Part of Staging Procedure for Gynaecological Malignancies: Single Institution Experience
title_short Robotic-Assisted Transperitoneal Aortic Lymphadenectomy as Part of Staging Procedure for Gynaecological Malignancies: Single Institution Experience
title_sort robotic-assisted transperitoneal aortic lymphadenectomy as part of staging procedure for gynaecological malignancies: single institution experience
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747409/
https://www.ncbi.nlm.nih.gov/pubmed/23983700
http://dx.doi.org/10.1155/2013/931318
work_keys_str_mv AT zanagnolov roboticassistedtransperitonealaorticlymphadenectomyaspartofstagingprocedureforgynaecologicalmalignanciessingleinstitutionexperience
AT rollod roboticassistedtransperitonealaorticlymphadenectomyaspartofstagingprocedureforgynaecologicalmalignanciessingleinstitutionexperience
AT tomasellit roboticassistedtransperitonealaorticlymphadenectomyaspartofstagingprocedureforgynaecologicalmalignanciessingleinstitutionexperience
AT rosenbergpg roboticassistedtransperitonealaorticlymphadenectomyaspartofstagingprocedureforgynaecologicalmalignanciessingleinstitutionexperience
AT bocciolonel roboticassistedtransperitonealaorticlymphadenectomyaspartofstagingprocedureforgynaecologicalmalignanciessingleinstitutionexperience
AT landonif roboticassistedtransperitonealaorticlymphadenectomyaspartofstagingprocedureforgynaecologicalmalignanciessingleinstitutionexperience
AT alettig roboticassistedtransperitonealaorticlymphadenectomyaspartofstagingprocedureforgynaecologicalmalignanciessingleinstitutionexperience
AT peirettim roboticassistedtransperitonealaorticlymphadenectomyaspartofstagingprocedureforgynaecologicalmalignanciessingleinstitutionexperience
AT sanguinetif roboticassistedtransperitonealaorticlymphadenectomyaspartofstagingprocedureforgynaecologicalmalignanciessingleinstitutionexperience
AT maggionia roboticassistedtransperitonealaorticlymphadenectomyaspartofstagingprocedureforgynaecologicalmalignanciessingleinstitutionexperience